Towards a 'Cure' for IBD

Digestive Diseases

Volumn 30, Issue 4, 2012, Pages 428-433

  Fiocchi, Claudio ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Crohn's disease; IBD cure; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; AROMATIC HYDROCARBON RECEPTOR; PREBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; COLON RESECTION; CROHN DISEASE; ENTERITIS; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; HEREDITY; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INTESTINE FLORA; MUCOSAL IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; TH1 CELL; TH2 CELL; ULCERATIVE COLITIS;

DISEASE PROGRESSION; ENVIRONMENT; GASTROINTESTINAL TRACT; HUMANS; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASES; METAGENOME;

EID: 84863963644     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000338148     Document Type: Article

References (29)

1. Xavier RJ, Podolsky D: Unraveling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434.
2. Cho JH, Brant SR: Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 2011;140:1704-1712, e1702.
3. Thompson AI, Lees CW: Genetics of ulcerative colitis. Inflamm Bowel Dis 2011; 17: 831-848.
4. Loftus EV: Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517.
5. Cohen ML: Changing patterns of infectious disease. Nature 2000; 406: 762-767.
6. Yazdanbakhsh M, Kremsner PG, vanRee R: Allergy, parasites, and the hygiene hypothesis. Science 2002; 296: 490-494.
7. Mulder IE, Schmidt B, Stokes CR, Lewis M, Bailey M, Aminov RI, et al: Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces. BMC Biol 2009; 7: 79.
8. Hviid A, Svanstrom H, Frisch M: Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011; 60: 49-54.
9. Ahima RS: Digging deeper into obesity. J Clin Invest 2011; 121: 2076-2079.
10. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI: Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-11075.
11. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
12. Yan X, Huang Y, Wang H, Du M, Hess BW, Ford SP, et al: Maternal obesity induces sustained inflammation in both fetal and offspring large intestine of sheep. Inflamm Bowel Dis 2011; 17: 1513-1522.
13. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al: Linking longterm dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-108.
14. Stevens EA, Bradfield CA: Immunology: T cells hang in the balance. Nature 2008; 453: 46-47.
15. Monteleone I, Rizzo A, Sarra M, Sica G, Sileri P, Biancone L, et al: Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 2011; 141: 237-248.
16. Gionchetti P, Campieri M: Probiotics and antibiotics in inflammatory bowel disease. Current Opin Gastroenterol 2001; 17: 331-335.
17. Barnes MJ, Powrie F: Immunology. The gut's Clostridium cocktail. Science 2011; 331: 289-290.
18. Porter DL, Levine BL, Kalos M, Bagg A, June CH: Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 2011; 365: 725-733.
19. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009; 10: 241-247.
20. Nathan C, Ding A: Nonresolving inflammation. Cell 2010; 140: 871-882.
21. Rappaport SM. Implications of the exposome for exposure science. J Expo Sci Environ Epidemiol 2011; 21: 5-9.
22. Rakyan VK, Down TA, Balding DJ, Beck S: Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011; 12: 529-541.
23. Shakespear MR, Halili MA, Irvine KM, Fairlie DP, Sweet MJ: Histone deacetylases as regulators of inflammation and immunity. Trends Immunol 2011; 32: 335-343.
24. Ruder WC, Lu T, Collins JJ: Synthetic biology moving into the clinic. Science. 2011; 333: 1248-1252.
25. Kugathasan S, Cohen S: Searching for new clues in inflammatory bowel disease: tell tales from pediatric IBD natural history studies. Gastroenterology 2008; 135: 1038-1041.
26. Fiocchi C: Early and late inflammatory bowel disease: why and how are they different? Curr Opin Gastroenterol 2011; 27: 317-320.
27. Schneider MV, Orchard S: Omics technologies, data and bioinformatics principles. Methods Mol Biol 2011; 719: 3-30.
28. Germain RN, Schwartzberg PL: The human condition: an immunological perspective. Nat Immunol 2011; 12: 369-372.
29. Barabasi AL: Network medicine -from obesity to the 'diseasome'. N Engl J Med 2007; 357: 404-407.